Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
This study is currently recruiting participants.
Verified June 2011 by Brigham and Women's Hospital
Study NCT01238588   Information provided by Brigham and Women's Hospital

First Received on November 9, 2010.   Last Updated on September 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dialysis
Cardiovascular Disease
Atherosclerosis
Inflammation
Hyperphosphatemia
Additional conditions recognized in this trial
Cardiovascular Diseases
Plaque, Atherosclerotic
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Metabolic Diseases
Pathologic Processes
Pathological Conditions, Anatomical
Phosphorus Metabolism Disorders
Vascular Diseases
Interventions listed in this trial
Sevelamer Carbonate (Renvela)
Additional drug interventions recognized in this trial
Sevelamer
More general drug interventions related to this trial
Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Brigham and Women's Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services